Market Overview
The global Smart Implants Market size was valued at USD 5.4 Billion in 2024 and is projected to reach USD 21.9 Billion by 2033. The market is expected to grow at a CAGR of 15.99% during the forecast period from 2025 to 2033. Growth is driven by technological advancements in healthcare and personalized medical solutions, with integration of sensors and IoT enabling real-time patient monitoring and better treatment outcomes.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
Smart Implants Market Key Takeaways
- The global smart implants market size was USD 5.4 Billion in 2024.
- The market is forecasted to grow at a CAGR of 15.99% between 2025 and 2033.
- North America leads the market with a significant share of over 40.2% in 2024.
- Increasing prevalence of chronic diseases like osteoporosis, arthritis, and cardiovascular conditions drive demand.
- Growing adoption of minimally invasive surgeries enhances market growth.
- Technological advancements including IoT integration and AI-driven analytics boost real-time monitoring and personalized care.
- Sample Request Link: https://www.imarcgroup.com/Smart-Implants-Market/requestsample
Market Growth Factors
The global smart implants market is projected to grow because chronic diseases such as osteoporosis, arthritis, diabetes, and cardiovascular diseases are increasingly common. International Diabetes Federation says diabetes around 2021 was in 10.5% of adults over 18 years old and should increase a lot before 2045, growing smart implant demand. Orthopedic implants with sensors can monitor how healing progresses, which allows doctors to detect complications earlier, reducing reoperation and improving recovery.
The market is expected to grow because of advances in sensor technology, IoT, and AI technology, the latter projected to reach USD 854.5 Billion by 2033 at a CAGR of 23.64 percent. These technologies could capture and transfer real-time data, remotely monitor patients, optimize personalized therapy and decide clinically. Improved biocompatible materials and 3D printing innovations are being applied also to orthopedics, cardiology, and neurology to improve personalized implants.
Demand regarding minimally intrusive techniques strengthens the case for smart implants. Smart implants offer pain reduction. Smart implants offer faster recovery. Smart implants offer fewer complications. Smart stents and pacemakers can be used during cardiovascular surgery to precisely position them and provide real-time feedback on their functioning, this improves outcomes. Further, it helps grow the global smart implants market when people become aware and demand advanced treatments that are friendly to patients.
Market Segmentation
By Product Type:
- Orthopedics Smart Implants: Includes knee arthroplasty, hip arthroplasty, spine fusion, fracture fixation, and others. The segment holds around 46.0% market share in 2024, driven by sensor-embedded implants that improve healing monitoring and patient recovery.
- Cardiovascular Smart Implants: Includes pacing devices, stents, and structural cardiac implants.
- Ophthalmic Smart Implants: Comprising intraocular lens and glaucoma implants.
- Dental Smart Implants
- Cosmetic Smart Implants
- Others
By Material:
- Bone Cement
- Metal (Cobalt, Alloy, Titanium): The leading material segment due to strength, toughness, corrosion resistance, and compatibility with sensor technologies.
- Others
By End User:
- Hospitals: Holding approximately 52.2% market share in 2024 owing to advanced infrastructure and comprehensive care systems enabling implant placement and monitoring.
- Ambulatory Surgical Centers
- Orthopedics Clinics
- Ophthalmic Clinics
- Dental Labs
- Others
Regional Insights
In 2024, North America dominated the smart implants market with over 40.2% market share. This leadership is attributable to advanced healthcare infrastructure, strong research and development capabilities, favorable regulatory policies, and high accessibility to advanced treatments. The United States accounts for more than 88.2% of North America's market, driven by rising adoption of dental implants, increased healthcare investments, and a growing geriatric population demanding advanced implant solutions.
Recent Developments & News
- December 2024: OSSIO, Inc. secured USD 27.6 Million funding to expand OSSIOfiber Smart Implants for bio-integrative orthopedic fixation, aiming at global market expansion.
- December 2024: North Oaks Orthopaedic Specialty Center introduced the ROSA Knee System leveraging robotic technology for precision in total knee arthroplasty.
- December 2024: Scripps Health received a $317,000 NIH grant for developing the first smart shoulder replacement implant to monitor post-surgery shoulder mechanics.
- November 2024: Zimmer Biomet received FDA approval for the Oxford Cementless Partial Knee Implant for U.S. launch in early 2025.
- November 2024: Exactech conducted its first surgery using the Equinoxe® Central Screw Baseplate implant, an advanced smart implant for shoulder care.
Key Players
- Abbott Laboratories
- Biotronik
- Boston Scientific Corporation
- Cochlear Limited
- CONMED Corporation
- Intelligent Implants
- IQ Implants USA
- Medronic plc
- Smart Implant Solutions USA
- Stryker Corporation
- Zimmer Biomet
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request For Customization: https://www.imarcgroup.com/request?type=report&id=12853&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
Share this page with your family and friends.